Trial intelligence / Profile preview

Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed IVF natural cycles

2024-512844-40-00Phase 4Authorised

Sponsor
Region Västra Götaland
Start
Jun 2024
Modality
Small Molecules
Countries
2
01

Overview

Phase 4, randomised, open-label trial of progesterone in infertility (2 arms), sponsored by Region Västra Götaland. Primary endpoint: Live birth. Planned start Jun 2024; status: authorised.

02

Drugs

progesterone
03

Conditions

infertility

Beyond the preview

Go deeper on 2024-512844-40-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-512844-40-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call